Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China · Delayed Price · Currency is CNY 11.07
+0.03 (0.27%)
Feb 4, 2026, 3:04 PM CST
SHE:300485 Revenue
Beijing Science Sun Pharmaceutical had revenue of 111.83M CNY in the quarter ending September 30, 2025, with 3.50% growth. This brings the company's revenue in the last twelve months to 402.23M, down -0.84% year-over-year. In the year 2024, Beijing Science Sun Pharmaceutical had annual revenue of 416.48M, down -12.61%.
Revenue (ttm)
402.23M
Revenue Growth
-0.84%
P/S Ratio
13.22
Revenue / Employee
784.07K
Employees
513
Market Cap
5.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 416.48M | -60.09M | -12.61% |
| Dec 31, 2023 | 476.57M | -257.98M | -35.12% |
| Jan 1, 2023 | 734.55M | -316.26M | -30.10% |
| Jan 1, 2022 | 1.05B | -43.42M | -3.97% |
| Dec 31, 2020 | 1.09B | -96.68M | -8.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Jianmin Pharmaceutical Group | 3.18B |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Bide Pharmatech | 1.27B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Nanjing Hicin Pharmaceutical | 615.39M |